Autologous Serum Eye Drops With Contact Lenses for Corneal Epithelial Defects

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Corneal Diseases
Interventions
DRUG

Continuous use of topical autologous serum

Silicone-hydrogel SCLs combined with 20% (v/v) autologous serum eye drops were used until complete re-epithelialization. SCLs were removed after total re-epithelialization and patients were subsequently randomized divided into two groups: (1) with and (2) without continuous use of topical autologous serum for an additional 2 weeks after SCLs removal.

Trial Locations (1)

Unknown

E-DA hospital, Kaohsiung City

All Listed Sponsors
lead

E-DA Hospital

OTHER

NCT02291731 - Autologous Serum Eye Drops With Contact Lenses for Corneal Epithelial Defects | Biotech Hunter | Biotech Hunter